Janssen Search
Search results
Luc Van Nueten
JOHAN L. J. VERBEECK, D.V.M., MS.c VICE PRESIDENT EXPERIMENTAL MEDICINE JANSSEN RESEARCH & DEVELOPMENT, LLC Luc is a highly regarded expert in early clinical and non-clinical development with a strong track record in developing and applying ...
Opening Vaccines Launch Facility
Article Type: Other About the Symposium The speakers include: Bruno Bruins- Minister for Medical Care and Sport of the Netherlands, Pierre Meulien of the EU’s Innovative Medicines Initiative (IMI), Jayasree K. Iyer of the Access to Vaccines Index (ATVI) ...
3 Innovative Ways Researchers are Rethinking How We Combat the Flu
3 Innovative Ways Researchers are Rethinking How We Combat the Flu Sep 24, 2020 Subhead: Lorem ipsum dolor sit amet, consectetuer adipiscing elit Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec ...
UEGW 2020 Newsroom Janssen Immunology R&D
Welcome to the Janssen Immunology UEGW 2020 Newsroom! Please see below for the latest meeting news, a message from our leaders, social feeds, and more information about our progress and commitment to developing innovative medicines for Inflammatory Bowel ...
ASCO GU 2021
Thank you for visiting the Janssen Oncology newsroom to learn more about our research that will be presented at the American Society of Clinical Oncology 2021 Genitourinary Cancers Symposium (ASCO GU). Janssen Oncology has 12 company-sponsored ...
Lung Cancer Awareness Redirect
Innovations in the Interception of Lung Cancer: How a Smartphone App May Aid Smoking Cessation in China Nov 09, 2021 Subhead: Lorem ipsum dolor sit amet, consectetuer adipiscing elit Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus ...
Innovative Research Approaches Bring Us Closer to Precision Medicine for Inflammatory Rheumatic Diseases
Innovative Research Approaches Bring Us Closer to Precision Medicine for Inflammatory Rheumatic Diseases Jun 06, 2023 Subhead: Lorem ipsum dolor sit amet, consectetuer adipiscing elit Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus ...
Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
May 02, 2023 United States Investigational CD20-targeted CAR-Ts Enhance Janssen’s B-cell Malignancy Portfolio Agreement Deepens Janssen’s Leadership in Oncology and Hematology, and Accelerates Commitment to Delivering Transformational Cell Therapies ...
The Patients Are Waiting – Paul Janssen
We are driven by our belief that patients are waiting and there is no time to waste. Dr. Paul Janssen at the University of Ghent, Belgium, laboratories in the early 1950s. There he obtained his Ph.D. in Medicine in 1951 and his Ph.D. in Pharmacology in ...
Tackling the Biggest Challenges in Global Health
World NTD Day 2022: Tackling the Biggest Health Challenges in Global Health Two billion. This World Neglected Tropical Diseases (NTD) Day, Johnson & Johnson is pleased to announce that this is the number of doses of mebendazole, our medicine to ...